Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex
- PMID: 1598672
Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex
Abstract
This study is a continuation of our previous work that showed that patients with thromboangiitis obliterans (TAO; Buerger's disease) demonstrate a cell-mediated immune response to human artery type-specific collagens. To investigate the role of cigarette smoking in patients with TAO, cellular and humoral sensitivity was tested to a tobacco glycoprotein (TGP) antigen in 13 patients with Buerger's disease, 16 healthy smokers, and 12 nonsmoking healthy young male subjects. In this study, patients with Buerger's disease and healthy smokers had the same rate of cellular response to TGP, whereas nonsmokers did not respond. All three groups had a 30% to 40% measurable antibody response to TGP. If TGP has an immunologic role in the pathogenesis of TAO, an additional factor (or factors) may be operative. A specific genetic makeup may be one such factor, although at this stage other pathogenic mechanisms cannot be ruled out. Eleven patients with Buerger's disease and two control groups of 10 young healthy smoking male subjects and 12 young nonsmokers underwent histocompatibility leukocyte antigen (HLA) typing. Patients with Buerger's disease had a statistically significantly higher frequency of HLA-DR4 and a significantly lower frequency of the HLA-DRW6 antigen than had both control groups. Because similar findings have been reported in other autoimmune diseases, this observation may serve as further evidence that an autoimmune mechanism is involved in Buerger's disease.
Similar articles
-
Cellular sensitivity to collagen in thromboangiitis obliterans.N Engl J Med. 1983 May 12;308(19):1113-6. doi: 10.1056/NEJM198305123081901. N Engl J Med. 1983. PMID: 6835334
-
Diagnostic criteria and treatment of Buerger's disease: a review.Int J Low Extrem Wounds. 2006 Jun;5(2):89-95. doi: 10.1177/1534734606288817. Int J Low Extrem Wounds. 2006. PMID: 16698911 Review.
-
HLA in Buerger's disease.Exp Clin Immunogenet. 1986;3(4):195-200. Exp Clin Immunogenet. 1986. PMID: 3274054
-
The role of autoimmunity in thromboangiitis obliterans (Buerger's disease).Ann N Y Acad Sci. 2013 May;1285:15-25. doi: 10.1111/nyas.12048. Epub 2013 Mar 19. Ann N Y Acad Sci. 2013. PMID: 23510296 Review.
-
[Buerger's disease].Cas Lek Cesk. 2006;145(5):358-62. Cas Lek Cesk. 2006. PMID: 16755770 Review. Czech.
Cited by
-
Thromboangiitis Obliterans (Buerger's Disease).Eplasty. 2015 Apr 10;15:ic22. eCollection 2015. Eplasty. 2015. PMID: 25987945 Free PMC article. No abstract available.
-
Stem cell therapy in patients with thromboangiitis obliterans: assessment of the long-term clinical outcome and analysis of the prognostic factors.Int J Stem Cells. 2011 Nov;4(2):88-98. doi: 10.15283/ijsc.2011.4.2.88. Int J Stem Cells. 2011. PMID: 24298340 Free PMC article.
-
Activation of cytokines corroborate with development of inflammation and autoimmunity in thromboangiitis obliterans patients.Clin Exp Immunol. 2012 Oct;170(1):28-35. doi: 10.1111/j.1365-2249.2012.04624.x. Clin Exp Immunol. 2012. PMID: 22943198 Free PMC article.
-
Ocular Manifestations of Buerger's Disease - A Review of Current Knowledge.Clin Ophthalmol. 2022 Mar 18;16:851-860. doi: 10.2147/OPTH.S352608. eCollection 2022. Clin Ophthalmol. 2022. PMID: 35330748 Free PMC article. Review.
-
The Association of HLA-A, B and DRB1 with Buerger's Disease.Rep Biochem Mol Biol. 2019 Jul;8(2):153-160. Rep Biochem Mol Biol. 2019. PMID: 31832439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials